bcl-2 gene expression in hematopoietic cell differentiation.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood.v80.3.768.768PMID 1638028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.

  1992cited by this paper
• A variant translocation t(2;18) in follicular lymphoma involves the 5' end of bcl-2 and Ig kappa light chain gene.

  1991cited by this paper
• Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia

  1990cited by this paper
• Mechanism of bcl-2 activation in human follicular lymphoma.

  1990cited by this paper
• Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.

  1990cited by this paper
• Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population

  1990cited by this paper
• Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.

  1989cited by this paper
• Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell.

  1989cited by this paper
• The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation

  1989cited by this paper
• T‐cell receptor genes expression in B‐cell leukaemias

  1989cited by this paper
• Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells.

  1989cited by this paper
• Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia.

  1989cited by this paper
• bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma.

  1989cited by this paper
• The bcl-2 gene encodes a novel G protein

  1989cited by this paper
• bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.

  1989cited by this paper
• Alternative promoters and exons, somatic mutation and deregulation of the Bcl‐2‐Ig fusion gene in lymphoma.

  1988cited by this paper
• Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.

  1988cited by this paper
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

  1988cited by this paper
• Human T cell gamma chain joining regions and T cell development.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.

  1987cited by this paper
• Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.

  1987cited by this paper
• Expression of the bcl‐2 gene in mouse B lymphocytic cell lines is differentiation stage specific

  1987cited by this paper
• Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer.

  1987cited by this paper
• Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.

  1987cited by this paper
• Immunoglobulin and T-cell receptor beta chain gene rearrangements as lineage markers in human leukemias: a study of 78 cases.

  1987cited by this paper
• Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas

  1986cited by this paper
• HLA-DR-associated invariant chain is highly expressed in chronic lymphocytic leukemia.

  1986cited by this paper
• Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

  1986cited by this paper
• Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

  1985cited by this paper
• Analysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell line.

  1985cited by this paper
• Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

  1985cited by this paper
• Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

  1984cited by this paper
• Sequence and expression of transcripts of the human T-cell receptor beta-chain genes.

  1984cited by this paper
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

  1983cited by this paper
• Nucleotide sequence of cloned cDNA of human c-myc oncogene

  1983cited by this paper
• Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed

  1983cited by this paper
• Organization of human histone genes.

  1982cited by this paper
• Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes

  1981cited by this paper
• Clustered arrangement of immunoglobulin λ constant region genes in man

  1981cited by this paper
• Clustered arrangement of immunoglobulin lambda constant region genes in man.

  1981cited by this paper
• Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments.

  1980cited by this paper
• Detection of specific sequences among DNA fragments separated by gel electrophoresis.

  1975cited by this paper

• Relationship between BCL-2 Oncogene Expression and Apoptosis in a Human Leukemia T Cell Line

  2021cites this paper
• 8 Pathophysiology of Protein Kinase C Isozymes in Chronic Lymphocytic Leukaemia

  2017cites this paper
• Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia

  2016cites this paper
• Expression Of The Bcl2 Gene In Chronic Lymphocytic Leukaemia Patients

  2015cites this paper
• A liquid chromatography/tandem mass spectrometry method for determination of obatoclax in human plasma.

  2014cites this paper
• Pathophysiology of Protein Kinase C Isozymes in Chronic Lymphocytic Leukaemia

  2012cites this paper
• leukemia Advances in the biology and treatment of B-cell chronic lymphocytic

  2011cites this paper
• Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells

  2007cites this paper
• Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia

  2007cites this paper
• Deguelin inhibits expression of IkappaBalpha protein and induces apoptosis of B-CLL cells in vitro.

  2007cites this paper
• Deguelin inhibits expression of IκBα protein and induces apoptosis of B-CLL cells in vitro

  2007cites this paper
• The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells

  2007cites this paper
• Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.

  2006cites this paper
• Bcl‐2 regulatory pathway is functional in chronic lymphocytic leukemia

  2005cites this paper
• Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27

  2005cites this paper
• The pattern of expression of the apoptotic inducer Fas and the apoptotic inhibitor bcl-2 oncogenes immunohistochemicaly in bone-marrow invaded by the non-Hodgkin lymphomas.

  2004cites this paper
• Interleukin‐6 is responsible for drug resistance and anti‐apoptotic effects in prostatic cancer cells

  2004cites this paper
• Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)

  2002cites this paper
• Induction of apoptosis by a ribosome-inactivating protein from Agrostemma githago is associated with down-regulation of anti-apoptotic bcl-2 protein expression.

  2001cites this paper
• Short Communication: Expression of Apoptosis Regulating Factors on T Lymphocytes in Multiple Myeloma Patients

  2001cites this paper
• Assessment of Apoptosis Regulating Factors BCL-2 and Fas Antigens on Malignant and Normal Plasma Cells

  2001cites this paper
• Expression of BAX in Plasma Cell Dyscrasias 1

  2000cites this paper
• Ubiquitin-Proteasome System and Increased Sensitivity of B-CLL Lymphocytes to Apoptotic Death Activation

  2000cites this paper
• The expression pattern of the AML1 gene in non-Hodgkin's B-cell lymphomas and normal B lymphocytes.

  2000cites this paper
• Expression of BAX in plasma cell dyscrasias.

  2000cites this paper
• Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin.

  2000cites this paper
• Inroads in the therapy of indolent lymphomas: exploiting biological insights.

  1999cites this paper
• Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.

  1999cites this paper
• Protease activation and glucocorticoid-induced apoptosis in chronic lymphocytic leukemia.

  1999cites this paper
• Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression.

  1999cites this paper
• Bcl-2 antisense therapy in multiple myeloma.

  1999cites this paper
• Drug-induced apoptosis in chronic lymphocytic leukemia

  1999cites this paper
• BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.

  1998cites this paper
• BCL-X expression in multiple myeloma: possible indicator of chemoresistance.

  1998cites this paper
• Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse.

  1998cites this paper
• Taxol can induce phosphorylation of BCL-2 in multiple myeloma cells and potentiate dexamethasone-induced apoptosis.

  1998cites this paper
• Chronic lymphocytic leukemia: staging and prognostic factors.

  1998cites this paper
• Trisomy 12 and t(14;18) in B-cell chronic lymphocytic leukemia.

  1998cites this paper
• Bcl-2 mRNA-targeted ribozymes: effects on programmed cell death in chronic myelogenous leukemia cell lines

  1998cites this paper
• Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells.

  1997cites this paper
• Functional adrenocortical adenoma in a case with B cell chronic lymphoproliferative disorder.

  1997cites this paper
• Expression of bcl-2 and Epstein-Barr virus LMP1 in lymphocytic interstitial pneumonia.

  1997cites this paper
• Genes and chromosomes in chronic B-cell leukemia.

  1997cites this paper
• Incidence of 5' bcl-2 rearrangement in patients with B cell chronic lymphocytic leukemia from India.

  1996cites this paper
• Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX.

  1996cites this paper
• Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide.

  1996cites this paper
• Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia

  1996cites this paper
• Flow-cytometric quantitation in chronic leukemias.

  1996cites this paper
• BCL-2 gene rearrangements in lymphoid malignancies.

  1996cites this paper
• Immunoreactivity for bcl‐2 protein in cutaneous lymphomas and lymphoid hyperplasias *

  1995cites this paper
• Advances in the biology and treatment of B-cell chronic lymphocytic leukemia.

  1995cites this paper
• Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.

  1995cites this paper
• Molecular pathology of low grade malignant lymphomas

  1995cites this paper
• The role of Epstein-Barr virus in the pathogenesis of lymphocytic interstitial pneumonia

  1995cites this paper
• Interleukin-6 inhibits apoptosis of malignant plasma cells.

  1995cites this paper
• Interferon‐alpha up‐regulates bcl‐2 expression and protects B‐CLL cells from apoptosis in vitro and in vivo

  1994cites this paper
• Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.

  1994cites this paper
• Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines.

  1994cites this paper
• BCL2 translocations in leukemias of mature B cells.

  1994cites this paper
• Maturation-dependent susceptibility to monocyte-mediated cytotoxicity in acute myeloid leukemia.

  1994cites this paper
• Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia.

  1994cites this paper
• BCL-2 induction is part of the strategy of Epstein-Barr virus.

  1994cites this paper
• Lack of 5' BCL2 rearrangements in B-cell leukemia.

  1993cites this paper
• Apoptosis in tumor necrosis factor-alpha-dependent, monocyte-mediated leukemic cell death: a functional, morphologic, and flow-cytometric analysis.

  1993cites this paper
• Bcl-2 protein in centrocytic lymphoma; a paraffin section study.

  1993cites this paper
• bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.

  1993cites this paper
• Apoptotic cell death in chronic lymphocytic leukemia.

  1993cites this paper
• Autoantigen inhibits apoptosis of a human B cell leukemia that produces pathogenic rheumatoid factor.

  1993cites this paper